Clinical implications of endotoxin activity and Polymyxin-B hemoperfusion in critically ill patients with septic cardiomyopathy: A single-center, retrospective, observational study.
Salvatore Lucio CutuliSimone CarelliLaura CascaranoSandra CicconiDavide SilvestriMarta CicettiMaria Sole VallecocciaGabriele PintaudiEloisa Sofia TanzarellaDomenico Luca GriecoMassimo AntonelliGennaro De PascalePublished in: Artificial organs (2023)
In septic patients, EA was not associated with SCM. However, endotoxin removal by Polymyxin-B hemoperfusion was associated with recovery from cardiomyopathy, which was a predictor of lower 28-day mortality.